These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17313513)

  • 1. Evaluation of pooled screening for anti-HCV in two blood services set-ups.
    Novack L; Shinar E; Safi J; Soliman H; Yaari A; Galai N; Pliskin JS; Sarov B
    Trop Med Int Health; 2007 Mar; 12(3):415-21. PubMed ID: 17313513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.
    Sarov B; Novack L; Beer N; Safi J; Soliman H; Pliskin JS; Litvak E; Yaari A; Shinar E
    Transfus Med; 2007 Dec; 17(6):479-87. PubMed ID: 17727618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development.
    García Z; Taylor L; Ruano A; Pavón L; Ayerdis E; Luftig RB; Visoná KA
    J Med Virol; 1996 Jul; 49(3):218-22. PubMed ID: 8818968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pooling on accuracy of hepatitis B virus surface antigen screening of blood donations.
    Novack L; Sarov B; Goldman-Levi R; Yahalom V; Safi J; Soliman H; Orgel M; Yaari A; Galai N; Pliskin JS; Shinar E
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):787-92. PubMed ID: 18486172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and cost-benefit of pooled versus singleton screening blood donations for anti-HIV: impact on different blood bank set-ups.
    Novack L; Pliskin JS; Shinar E; Safi J; Sarov B
    Trop Doct; 2006 Oct; 36(4):236-9. PubMed ID: 17034705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.
    Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B
    Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-effective algorithm for the diagnosis of Hepatitis C virus infection and prediction of HCV viremia in Cameroon.
    Njouom R; Tejiokem MC; Zanga MC; Pouillot R; Ayouba A; Pasquier C; Nerrienet E
    J Virol Methods; 2006 May; 133(2):223-6. PubMed ID: 16360220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions.
    Berger A; Rabenau H; Allwinn R; Doerr HW
    J Clin Virol; 2008 Oct; 43(2):158-61. PubMed ID: 18635393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
    Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
    Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical and economic evaluation of donated blood screening for hepatitis C and non-A, non-B, non-C hepatitis].
    Vergnon P; Colin C; Jullien AM; Bory E; Excoffier S; Matillon Y; Trepo C
    Rev Epidemiol Sante Publique; 1996 Jan; 44(1):66-79. PubMed ID: 8851944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C lookback in Canada.
    Goldman M; Long A
    Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of immunoassay chromatography test for hepatitis-C antibodies detection.
    Batool A; Khan MI; Bano KA
    J Ayub Med Coll Abbottabad; 2009; 21(3):38-9. PubMed ID: 20929009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels.
    Sarov B; Novack L; Galai N; Yaari A; Orgel M; Safi J; Yahalom V; Shinar E
    Clin Microbiol Infect; 2007 Jul; 13(7):737-9. PubMed ID: 17441976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance characteristics of the ARCHITECT anti-HCV assay.
    Jonas G; Pelzer C; Beckert C; Hausmann M; Kapprell HP
    J Clin Virol; 2005 Oct; 34(2):97-103. PubMed ID: 16122974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia.
    Ol HS; Bjoerkvoll B; Sothy S; Van Heng Y; Hoel H; Husebekk A; Gutteberg T; Larsen S; Husum H
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):963-71. PubMed ID: 19842380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus.
    Scheiblauer H; El-Nageh M; Nick S; Fields H; Prince A; Diaz S
    Transfusion; 2006 May; 46(5):708-18. PubMed ID: 16686838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus window-phase infections: closing the window on hepatitis C virus.
    Tuke PW; Grant PR; Waite J; Kitchen AD; Eglin RP; Tedder RS
    Transfusion; 2008 Apr; 48(4):594-600. PubMed ID: 18194388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.